Lengo Therapeutics
Menlo Park, US · Founded 2019 · Delaware corporation · 1 known investors
Biotech
Founders & leadership
DE
Daniel Estes, Ph.D.President
TS
Tracy Saxton, Ph.D.Director
HJ
Helen JenkinsChief Executive Officer
RU
Roger Ulrich, Ph.D.Director
SB
Steve BaileyVice President
AC
Anna ChenTreasurer and Secretary
DJ
David JohnsonDirector
JS
JIA SHENG LOOExecutive Officer, Director, Promoter
Investors · 1
Reported raises · per SEC filings
Form D private placements▶$7MofferedApr 2023 · Other TechnologyRule 506(c)
▶$7MofferedApr 2023 · Other Technology
Rule 506(c)Officers, directors & promoters on the filing
- JIA SHENG LOOExecutive Officer, Director, Promoter
- Offering amount
- $7M
- Placement agents
- JIA SHENG LOO
- Incorporated
- Corporation, New York, 2023
- Federal exemptions
- 06c
▶$17.7MraisedApr 2021 · 4 investors · PharmaceuticalsRule 506(b)
▶$17.7MraisedApr 2021 · 4 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Daniel Estes, Ph.D.Executive Officer, Director
- Tracy Saxton, Ph.D.Director
- Helen JenkinsExecutive Officer, Director
- Roger Ulrich, Ph.D.Director
- Steve BaileyExecutive Officer
- Anna ChenExecutive Officer
- David JohnsonDirector
- Offering amount
- $17.7M
- Amount sold
- $17.7M
- First sale
- Mar 2020
- Incorporated
- Corporation, Delaware, 2019
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.